Literature DB >> 11684869

Growth hormone receptor signalling and actions in bone growth.

P A Kelly1, J Finidori, S Moulin, C Kedzia, N Binart.   

Abstract

Growth hormone (GH) acts by binding to a membrane receptor that is part of the cytokine receptor superfamily. Ligand binding induces receptor dimerization leading to activation of the associated tyrosine kinase, Janus kinase (Jak) 2. Transphosphorylation of Jak2 occurs followed by tyrosine phosphorylation of the receptor, and numerous cytoplasmic proteins. Among these are the signal transducers and activators of transcription (Stat) proteins, as well as adaptor proteins leading to the activation of the Ras/mitogen-activated protein (MAP) kinase and the phosphatidyl-inositol-3'-kinase (PI 3-kinase) pathways. Activation of the GH receptor system is relatively transient, with several mechanisms being involved in down-regulation: internalization and degradation of the receptor and recruitment of phosphatases or specific inhibitors of the Jak-Stat pathway, the suppressors of cytokine signalling (SOCS) proteins. Finally, the use of the GH receptor knock-out mouse model has allowed us to dissect the role of this hormone in post-natal body growth and homeostasis. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684869     DOI: 10.1159/000063467

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  6 in total

1.  Immune and inflammatory pathways are involved in inherent bone marrow ossification.

Authors:  Umut Atakan Gurkan; Ryan Golden; Vipuil Kishore; Catherine P Riley; Jiri Adamec; Ozan Akkus
Journal:  Clin Orthop Relat Res       Date:  2012-09       Impact factor: 4.176

2.  Short stature in partially corrected X-linked severe combined immunodeficiency--suboptimal response to growth hormone.

Authors:  Suk See De Ravin; Elaine Shum; Kol A Zarember; Geoffrey Rezvani; Ron G Rosenfeld; Constantine A Stratakis; Harry L Malech
Journal:  J Pediatr Endocrinol Metab       Date:  2008-11       Impact factor: 1.634

3.  Inherent sexually dimorphic expression of hepatic CYP2C12 correlated with repressed activation of growth hormone-regulated signal transduction in male rats.

Authors:  Chellappagounder Thangavel; Bernard H Shapiro
Journal:  Drug Metab Dispos       Date:  2008-06-16       Impact factor: 3.922

Review 4.  Ion channels and cancer.

Authors:  Karl Kunzelmann
Journal:  J Membr Biol       Date:  2005-06       Impact factor: 2.426

5.  Expression of osteotropic growth factors and growth hormone receptor in a canine distraction osteogenesis model.

Authors:  Lars F H Theyse; Marja A Oosterlaken-Dijksterhuis; Jaap van Doorn; Maarten Terlou; Jan A Mol; George Voorhout; Herman A W Hazewinkel
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.976

6.  Connective tissue growth factor promotes chemotaxis of preosteoblasts through integrin α5 and Ras during tensile force-induced intramembranous osteogenesis.

Authors:  Wei Jiang; Nobuo Takeshita; Toshihiro Maeda; Chisumi Sogi; Toshihito Oyanagi; Seiji Kimura; Michiko Yoshida; Kiyo Sasaki; Arata Ito; Teruko Takano-Yamamoto
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.